mhurhangee/ep-ind-claims huggingface dataset:
An autostereoscopic display having a pass through transparent function, comprising: a display panel having an array of light emitting display pixels occupying pixel areas, and a light transmissive area between the pixel areas; and a polarizer at only the light transmissive area, wherein the light emitting display pixels provide light of a first polarization which is orthogonal to a second polarization passed by the polarizer; and an image forming arrangement (10,12) for directing images from different sets of pixels in different lateral viewing directions thereby enabling autostereoscopic viewing, wherein the image forming arrangement (10,12) is provided over one or both sides of the display, wherein the image forming arrangement is used to form autostereoscopic images using light of the first polarization, whereas light of the second polarization is used for the pass through transparent function. a display panel having an array of light emitting display pixels occupying pixel areas, and a light transmissive area between the pixel areas; and a polarizer at only the light transmissive area, wherein the light emitting display pixels provide light of a first polarization which is orthogonal to a second polarization passed by the polarizer; and an image forming arrangement (10,12) for directing images from different sets of pixels in different lateral viewing directions thereby enabling autostereoscopic viewing, wherein the image forming arrangement (10,12) is provided over one or both sides of the display, wherein the image forming arrangement is used to form autostereoscopic images using light of the first polarization, whereas light of the second polarization is used for the pass through transparent function.
A multistage centrifugal pump assembly with at least three impellers (2, 6), wherein two impeller groups (4, 8) which are consecutive in the flow direction are present, characterised in that the first impeller group is designed in at least two-stage manner with two impellers which are successively arranged in the flow direction, a backflow channel which connects the exit side of the first impeller group to its entry side is present in a first impeller group, and the second impeller group comprises at least one impeller.
Compound of formula: wherein: each R1 is independently selected from a benzyl group and a benzoyl group, optionally substituted with one or more substituents chosen from a nitro group (NO 2), an alkyl group and halogen, and R2 is selected from hydrogen, an acyl group, a monophosphate, diphosphate or triphosphate, or a stabilized phosphate derivative selected from a group and a group, wherein Ar and Ar' are phenyl or naphthyl groups optionally substituted with one or more halogen atoms, and R, R', R" and R'" are independently selected from a hydrogen atom, a hydroxyl group, an alkyl, a phenyl, and a NRaRb amine group, wherein Ra and Rb are selected from hydrogen atoms, alkyls and haloalkyls, a tautomer or enantiomer thereof, or a pharmaceutically acceptable salt thereof, or a mixture thereof, for use in the treatment of a viral infection. each R1 is independently selected from a benzyl group and a benzoyl group, optionally substituted with one or more substituents chosen from a nitro group (NO 2), an alkyl group and halogen, and R2 is selected from hydrogen, an acyl group, a monophosphate, diphosphate or triphosphate, or a stabilized phosphate derivative selected from a group and a group, wherein Ar and Ar' are phenyl or naphthyl groups optionally substituted with one or more halogen atoms, and R, R', R" and R'" are independently selected from a hydrogen atom, a hydroxyl group, an alkyl, a phenyl, and a NRaRb amine group, wherein Ra and Rb are selected from hydrogen atoms, alkyls and haloalkyls, a tautomer or enantiomer thereof, or a pharmaceutically acceptable salt thereof, or a mixture thereof, for use in the treatment of a viral infection.
A flame-retardant thermoplastic resin composition comprising a thermoplastic resin containing a repeating unit having an arylene group, an ether group, and a carbonyl group and a thermoplastic fluorine-containing resin, wherein the weight ratio of the thermoplastic resin and the thermoplastic fluorine-containing resin in the former/the latter is 95/5 to 99/1, wherein the thermoplastic fluorine-containing resin is dispersed in the form of particles in the thermoplastic resin to form a dispersed phase, and the dispersed phase has an average particle diameter of not more than 0.7 μm, the average particle diameter of the dispersed phase being determined by observing a sheet formed from the thermoplastic resin composition with a transmission electron microscope and binarizing the resulting image with an optically analyzing apparatus to calculate the average particle diameter of the dispersed phase, and wherein the thermoplastic fluorine-containing resin comprises a copolymer of tetrafluoroethylene and at least one member selected from the group consisting of hexafluoropropylene and a perfluoro(C 1-3 alkyl vinyl ether).
A medical tubing connector comprising: a first connector portion configured for connecting to a mating second connector, a tube engagement portion integral with and opposite the first connector portion and configured for connecting to a medical tube, a liquid passage extending axially through the first connector portion and the tube engagement portion, the first connector portion including a continuous outer surface for sealing engagement with the mating second connector, an annular portion integral with and surrounding the first connector portion, and a connecting portion connecting the first connector portion to the annular portion, the connecting portion being discontinuous permitting liquid to pass through the connecting portion so that liquid is prevented from pooling between the first connector portion and the annular portion, characterized by the connecting portion being defined by: a pair of spaced apart connecting arms extending in a first direction axially from the annular portion in the tube engagement direction, and further extending in a second direction radially to the first connector portion forming an 'L' shape; and further defined by a pair of arcuate openings at sides of the 'L' shaped connecting arms that communicate with an interior space of the annular portion to create secondary passages around the first connector portion and past the connecting portion. a first connector portion configured for connecting to a mating second connector, a tube engagement portion integral with and opposite the first connector portion and configured for connecting to a medical tube, a liquid passage extending axially through the first connector portion and the tube engagement portion, the first connector portion including a continuous outer surface for sealing engagement with the mating second connector, an annular portion integral with and surrounding the first connector portion, and a connecting portion connecting the first connector portion to the annular portion, the connecting portion being discontinuous permitting liquid to pass through the connecting portion so that liquid is prevented from pooling between the first connector portion and the annular portion, characterized by the connecting portion being defined by: a pair of spaced apart connecting arms extending in a first direction axially from the annular portion in the tube engagement direction, and further extending in a second direction radially to the first connector portion forming an 'L' shape; and further defined by a pair of arcuate openings at sides of the 'L' shaped connecting arms that communicate with an interior space of the annular portion to create secondary passages around the first connector portion and past the connecting portion.
A fibrous nonwoven fabric comprising a resin composition comprising a high-crystalline polyolefin and a low-crystalline polyolefin, the fibrous nonwoven fabric satisfying the following conditions and: a half-crystallization time (t a) of the high-crystalline polyolefin and a half-crystallization time (t b) of the low-crystalline polyolefin satisfy a relation of t a < t b; and a half-crystallization time (t c) of the resin composition is 1.2 to 2.0 times the half-crystallization time (t a) of the high-crystalline polyolefin, wherein the fibrous nonwoven fabric is a spunbonded nonwoven fabric constituted of fibers having a fineness of 0.2 to 0.8 deniers, and the half-crystallization time is measured using FLASH DSC, wherein the sample is melted by heating at 230 °C for 2 minutes and then cooled to 25 °C at a rate of 2,000 °C/sec, and a time change of heating value in an isothermal crystallization process at 25 °C is measured, and when an integrated value of heating value from start of the isothermal crystallization to completion of the crystallization is defined as 100 %, a time from start of the isothermal crystallization until the integrated value of heating value reaches 50 % is defined as the half-crystallization time. a half-crystallization time (t a) of the high-crystalline polyolefin and a half-crystallization time (t b) of the low-crystalline polyolefin satisfy a relation of t a < t b; and a half-crystallization time (t c) of the resin composition is 1.2 to 2.0 times the half-crystallization time (t a) of the high-crystalline polyolefin,
Mixed-layer clay mineral for use as a means of preventing and/or treating chronic inflammatory bowel diseases (CIBD), characterized in that the clay mineral is before use milled to a particle size of less than 5 μm and then heat-treated at a temperature between 300°C and 500°C, preferably between 350°C and 450°C, for a period of 1 h to 5 h, preferably 1 h to 3 h.
A system (100, 200, 300) comprising: at least one optical crystal (112, 212, 312) configured to receive at least one incident signal and to convert a wavelength of at least a portion of the incident signal; characterized in that the system (100, 200, 300) further comprises: a housing (102, 202, 302) having a chamber (104, 204, 304) formed in the housing (102, 202, 302), wherein the at least one optical crystal (112, 212, 312) is disposed in the chamber (104, 204, 304); and at least one shape memory alloy element (114, 214, 314) disposed such that thermal or electrical energy applied to the shape memory alloy element (114, 214, 314) causes translational movement of the optical crystal (112, 212, 314). at least one optical crystal (112, 212, 312) configured to receive at least one incident signal and to convert a wavelength of at least a portion of the incident signal; characterized in that the system (100, 200, 300) further comprises: a housing (102, 202, 302) having a chamber (104, 204, 304) formed in the housing (102, 202, 302), wherein the at least one optical crystal (112, 212, 312) is disposed in the chamber (104, 204, 304); and at least one shape memory alloy element (114, 214, 314) disposed such that thermal or electrical energy applied to the shape memory alloy element (114, 214, 314) causes translational movement of the optical crystal (112, 212, 314). a housing (102, 202, 302) having a chamber (104, 204, 304) formed in the housing (102, 202, 302), wherein the at least one optical crystal (112, 212, 312) is disposed in the chamber (104, 204, 304); and at least one shape memory alloy element (114, 214, 314) disposed such that thermal or electrical energy applied to the shape memory alloy element (114, 214, 314) causes translational movement of the optical crystal (112, 212, 314).
A computer implemented motion estimation method for estimating motion in video data containing a plurality of frames, the motion estimation method comprising: determining whether a current frame unit for which motion estimation is to be performed corresponds to a double block, the double block corresponding to one pair of neighboring single blocks to be processed together; when the current frame unit corresponds to the double block, acquiring a candidate vector set corresponding to a first single block included in the double block, as a candidate vector set of the double block; characterised in that: the candidate vector set comprises spatial candidate vectors, temporal candidate vectors, and random candidate vectors; and the method further comprising: individually calculating a confidence function value of each candidate vector included in the candidate vector set of the double block, for the first single block and a second single block included in the double block; acquiring an estimated motion vector of the first single block by selecting a candidate vector having a minimum confidence function value for the first single block among the candidate vectors of the first single block and acquiring an estimated motion vector of the second single block by selecting a candidate vector having a minimum confidence function value for the second single block among the candidate vectors of the second single block; and changing the frame unit to be processed to a subsequent frame unit. determining whether a current frame unit for which motion estimation is to be performed corresponds to a double block, the double block corresponding to one pair of neighboring single blocks to be processed together; when the current frame unit corresponds to the double block, acquiring a candidate vector set corresponding to a first single block included in the double block, as a candidate vector set of the double block; the candidate vector set comprises spatial candidate vectors, temporal candidate vectors, and random candidate vectors; and the method further comprising: individually calculating a confidence function value of each candidate vector included in the candidate vector set of the double block, for the first single block and a second single block included in the double block; acquiring an estimated motion vector of the first single block by selecting a candidate vector having a minimum confidence function value for the first single block among the candidate vectors of the first single block and acquiring an estimated motion vector of the second single block by selecting a candidate vector having a minimum confidence function value for the second single block among the candidate vectors of the second single block; and changing the frame unit to be processed to a subsequent frame unit.
A system, comprising: a multi-fuel gas turbine configured to operate on both a liquid fuel system and a gas fuel system, wherein the multi-fuel gas turbine comprises a compressor, a combustor, and a turbine; a gas fuel purge system configured to purge a gas fuel circuit of the gas fuel system during liquid fuel operation of the gas turbine, wherein the gas fuel purge system is characterized by being configured to: initially purge the gas fuel circuit with air prior to meeting a steam injection permissive threshold; and subsequently purge the gas fuel circuit with steam upon meeting the steam injection permissive threshold, and a controller configured to control the gas fuel purge system and the sequential purging of the gas fuel circuit with air and steam. a multi-fuel gas turbine configured to operate on both a liquid fuel system and a gas fuel system, wherein the multi-fuel gas turbine comprises a compressor, a combustor, and a turbine; a gas fuel purge system configured to purge a gas fuel circuit of the gas fuel system during liquid fuel operation of the gas turbine, wherein the gas fuel purge system is characterized by being configured to: initially purge the gas fuel circuit with air prior to meeting a steam injection permissive threshold; and subsequently purge the gas fuel circuit with steam upon meeting the steam injection permissive threshold, and a controller configured to control the gas fuel purge system and the sequential purging of the gas fuel circuit with air and steam.
A device for delivering a treatment medium to an eye, comprising: a first body portion and a second body portion; the second body portion being configured for carrying a treatment medium; wherein the first body portion is configured and arranged to be removably secured within a natural opening comprising a single punctum of the eye; and wherein the delivery device is configured and arranged such that when at least a part of the first body portion is removably inserted into the punctum, the device occludes or plugs the punctum; and further wherein the first and second body portions are configured and arranged such that the second body portion rests on the punctum, characterised in that the second body portion comprises a coating that is applied to an end segment of the first portion, which coating is configured or arranged so the treatment medium is controllably released from the second body portion to the eye. a first body portion and a second body portion; the second body portion being configured for carrying a treatment medium; wherein the first body portion is configured and arranged to be removably secured within a natural opening comprising a single punctum of the eye; and wherein the delivery device is configured and arranged such that when at least a part of the first body portion is removably inserted into the punctum, the device occludes or plugs the punctum; and further wherein the first and second body portions are configured and arranged such that the second body portion rests on the punctum, characterised in that the second body portion comprises a coating that is applied to an end segment of the first portion, which coating is configured or arranged so the treatment medium is controllably released from the second body portion to the eye.
A method of detecting circulating allogeneic therapeutic cells in a blood sample comprising: a. assaying circulating allogeneic therapeutic cells and human peripheral blood mononuclear cells to identify one or more markers positive for allogeneic therapeutic cells and one or more markers positive for patient peripheral blood mononuclear cells; b. comparing the one or more markers positive for circulating allogeneic therapeutic cells and the one or more markers positive for patient peripheral blood mononuclear cells to identify one or more unique markers which distinguishes the allogeneic therapeutic cells from the patient peripheral blood mononuclear cells; c. analyzing a blood sample from a patient that has been treated with allogeneic therapeutic cells using an assay method to detect the one or more unique markers positive for the circulating allogeneic therapeutic cells; and d. distinguishing between the patient peripheral blood mononuclear cells and circulating allogeneic therapeutic cells based on the detection of the one or more unique markers; wherein the circulating allogeneic therapeutic cells are human umbilical cord tissue-derived cells, and wherein the one or more unique markers for circulating human umbilical cord tissue-derived cells comprises CD10, CD13, NRP1, LAMP1, DKK3, or LAMB1. a. assaying circulating allogeneic therapeutic cells and human peripheral blood mononuclear cells to identify one or more markers positive for allogeneic therapeutic cells and one or more markers positive for patient peripheral blood mononuclear cells; b. comparing the one or more markers positive for circulating allogeneic therapeutic cells and the one or more markers positive for patient peripheral blood mononuclear cells to identify one or more unique markers which distinguishes the allogeneic therapeutic cells from the patient peripheral blood mononuclear cells; c. analyzing a blood sample from a patient that has been treated with allogeneic therapeutic cells using an assay method to detect the one or more unique markers positive for the circulating allogeneic therapeutic cells; and d. distinguishing between the patient peripheral blood mononuclear cells and circulating allogeneic therapeutic cells based on the detection of the one or more unique markers; wherein the circulating allogeneic therapeutic cells are human umbilical cord tissue-derived cells, and wherein the one or more unique markers for circulating human umbilical cord tissue-derived cells comprises CD10, CD13, NRP1, LAMP1, DKK3, or LAMB1.
Arrangement which comprises a fuel nozzle for dispensing a liquid and also comprises a product badge plate, which is connected to the fuel nozzle, the arrangement comprising an identification tab, characterized in that the identification tab comprises a connecting portion and an identification portion for displaying a piece of information, wherein the connecting portion is clamped in between a clamping surface of the product badge plate and a mating clamping surface of the fuel nozzle.
Method of producing a hardened steel component with a coating of zinc or of a zinc alloy, wherein a blank is stamped out of a sheet coated with the zinc or zinc alloy, the stamped out blank is heated to a temperature ≥Ac 3 and, if necessary, held at this temperature for a predetermined time to allow austenite to form, after which the heated blank is transferred into a forming tool, is formed in the forming tool at a speed which exceeds the critical hardening speed, is cooled down and is hardened thereby, in which the steel material is delayed in its conversion such that, at a forming temperature in the range of 450°C to 700°C and below the peritectic temperature of the zinc-iron system, quench hardening to convert the austenite into martensite takes place, upon which, after heating and before the conversion, active cooling takes place wherein the blank or parts of the blank is/are cooled down at a cooling speed >15K/sec wherein a steel material is used with the following analysis (all data in % by mass): Carbon 0.08-0.6 Manganese (Mn) 0.8-3.0 Aluminium (Al) 0.01-0.07 Silicon (Si) 0.01-0.5 Chromium (Cr) 0.02-0.6 Titanium (Ti) 0.01-0.08 Nitrogen < 0.02 Boron 0.002-0.02 Phosphorus < 0.01 Sulphur <0.01 Molybdenum (Mo) < 1 the remainder being iron and impurities caused by the melting, and progress of the cooling and/or the temperature at the which the material is loaded into the forming tool is monitored by means of sensors, in particular pyrometers, and the cooling is controlled accordingly where the blank is then heated in a furnace to a temperature >Ac 3 and is held for a predetermined time, wherein the blank is cooled down to a temperature between 500°C and 600°C in order to harden the layer of zinc, after which it is then transferred into the forming tool where it is formed.
An adhesive transfer system for applying a pattern of adhesive to a web of tipping paper as it is being fed through a smoking article filter assembly unit, the system comprising a transfer roller and an applicator roller, the transfer roller having a plurality of engraved regions forming a pattern on its surface that corresponds to the pattern of adhesive to be applied to the tipping paper web, the applicator roller being nipped with the transfer roller so that adhesive received on its surface is transferred from said engraved regions onto the applicator roller as the transfer roller and applicator roller rotate to form an adhesive pattern on the applicator roller for subsequent transfer onto a moving web of tipping paper in contact with said applicator roller, characterised in that said engraved regions each comprise a plurality of individual adhesive containing cells to break up adhesive over each of the engraved regions of the transfer roller.